Clinical trial
A Large Scale, Multicenter, Real-World Study on Patients With Advanced GIST Receiving Ripretinib
NCT05697107 is registered in ClinicalTrials.gov with Peking University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Large Scale, Multicenter, Real-World Study on Patients With Advanced GIST Receiving Ripretinib
- Lead sponsor
- Peking University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 20, 2021
- Completion date
- December 30, 2023
- Enrollment
- 308 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.